Suggested Topics within your search.
Suggested Topics within your search.
- Nurse and patient 1
- Nursing 1
- Practice 1
-
741
Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)
Published 2025-01-01“…Introduction Crohn’s disease (CD) is a chronic, immune-mediated inflammatory bowel disease (IBD), presenting with symptoms of abdominal pain and bleeding from the gastrointestinal tract. …”
Get full text
Article -
742
Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT)
Published 2022-06-01“…Introduction Ulcerative colitis (UC) and irritable bowel syndrome (IBS) are distressing chronic diseases associated with abdominal pain and altered bowel habits of unknown aetiology. …”
Get full text
Article -
743
-
744
-
745
The First Saint Petersburg Regional Inflammatory Bowel Diseases Registry on the Basis of the Regional Health Information System: Principles of Functioning, Testing Results, Plan of Development
Published 2023-11-01Subjects: “…inflammatory bowel diseases…”
Get full text
Article -
746
The Impact of Chronic Pelvic Pain and Bowel Morbidity on Quality of Life in Cervical Cancer Patients Treated With Radio (Chemo) Therapy....
Published 2025-02-01Subjects: Get full text
Article -
747
-
748
Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
Published 2024-12-01Subjects: “…irritable bowel syndrome…”
Get full text
Article -
749
Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink
Published 2025-01-01“…It included adults newly diagnosed with inflammatory bowel disease and established on 5-aminosalicylic acid (5-ASA) treatment between 1 January 2007 and 31 December 2019. …”
Get full text
Article -
750
Small intestinal bacterial overgrowth in patients with systemic sclerosis
Published 2017-01-01Subjects: Get full text
Article -
751
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators
Published 2025-12-01Subjects: “…Irritable bowel syndrome…”
Get full text
Article -
752
Ulcerative colitis: STRIDE-ing beyond symptoms with new standards
Published 2024-02-01Subjects: Get full text
Article -
753
Stem cells in gastroenterology: prospects and problems
Published 2011-12-01Subjects: Get full text
Article -
754
Exacerbation of polyethylene microplastics in animal models of DSS-induced colitis through damage to intestinal epithelial cell conjunctions
Published 2025-01-01Subjects: Get full text
Article -
755
Modern Possibilities of Using Lactulose in Clinical Practice
Published 2023-11-01Subjects: “…obstipation type of irritable bowel syndrome…”
Get full text
Article -
756
Unique laparoscopic emergency management of traumatic obstructed abdominal wall hernia: A case report and review of literature
Published 2024-07-01Subjects: Get full text
Article -
757
-
758
Health benefits of algae and marine-derived bioactive metabolites for modulating ulcerative colitis symptoms
Published 2025-02-01Subjects: “…Seaweed, Fucoidan, Fucoxanthin, Fish oil, Inflammatory bowel disease, Ulcerative colitis.…”
Get full text
Article -
759
Data mining and analysis of adverse events of Vedolizumab based on the FAERS database
Published 2025-01-01Subjects: Get full text
Article -
760
COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA)
Published 2023-12-01Subjects: “…irritable bowel syndrome…”
Get full text
Article